BPC-157 Arginate

Regenerative

Tissue-repair positioning with oral-stability claims

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Peptide salt
Primary mechanism: BPC-157 derivative formulation
Primary market use: Recovery / GI

Pharmacology

Molecular weight (Da): ~1593
Oral bioavailability: Unknown/low
Half-life: ~5–60 min parent peptide; analogs may be longer
Route tags: Oral
Evidence level: Preclinical
Clinical status: Experimental
Value-for-money score: 7 / 10

Reported protocol signal

Treatment length: Not for long term 30 days (Tailor Made Compounding Catalog) 8 weeks, followed by a 2-week rest. Can repeat another cycle if needed (World of Peptides) SQ: • Start slow with 100 mcg daily • 300 mcg daily (Tailor Made Compounding Catalog) • 250 mcg twice a day (reports from Discord and Reddit) • 200-300 mcg twice a day at the location of pain/injury (Metabolic Optimization Guide) Oral: • 500 mcg capsules twice a day IM: • 150 mcg twice a day at the location of pain/injury (World of Peptides)

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Derivative classification follows BPC-157 but evidence varies

Sources

https://pubmed.ncbi.nlm.nih.gov/